Insulin-stimulated glucose uptake in peripheral tissues is augmented by clenbuterol
HIGH INSULIN
The primary outcome of the study, peripheral insulin-stimulated glucose disposal, was assessed by a two-step hyperinsulinemic-euglycemic clamp using stable isotope-labeled glucose performed after 14 days of clenbuterol treatment vs. placebo. The change in insulin-stimulated glucose disposal in the high insulin phase over baseline (ΔRd) was ~13% higher upon clenbuterol treatment (